SHPH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.08% compare to its pairs and should correct downwards.

Stats
Today's Volume	54 023
Average Volume	52 125
Market Cap	6.71M
EPS	$-0.100 ( Q1 \| 2024-05-13 )
Next earnings date	( $0 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.850 (Sector) 42.63 (Industry) 30.78
ATR14	$0.00900 (2.25%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2024-06-13	Lorber Timothy J.	Sell	0	COMMON STOCK
2022-12-29	Senanayake Chris	Sell	1 626	COMMON STOCK
2024-03-08	Vander Hoek Michael	Buy	100 000	COMMON STOCK
2023-12-13	Brown Milton	Sell	2 921	Common Stock
2023-12-13	Jacobs Bette	Sell	4 157	Common Stock

INSIDER POWER
3.82
Last 30 transactions
Buy: 2 363 889 \| Sell: 2 132 232

Correlation (AI algo v.1.1b): Overvalued: -0.08% $0.400 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.15 (neutral)

Short: 0.34 (neutral)

Signal:(52.547) Neutral

Shuttle Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shuttle Pharmaceuticals Correlation - Currency/Commodity

-0.43
( neutral )

-0.17
( neutral )

0.00
( neutral )

0.54
( weak )

Shuttle Pharmaceuticals Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-6 811.00 (0.00 %)
EPS:	$-0.440

FY	2023
Revenue:	$0
Gross Profit:	$-6 811.00 (0.00 %)
EPS:	$-0.440

FY	2022
Revenue:	$0
Gross Profit:	$-66 832.00 (0.00 %)
EPS:	$-0.300

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.0856

Financial Reports:

No articles found.

Shuttle Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.